JP Morgan Chase
BTCY

JP Morgan Chase’s Biotricity, Inc. Common Stock BTCY Stock Holding History

JP Morgan Chase’s Portfolio BTCY Stock Details BTCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-8
Closed -$17 – 7967
2023
Q3 		$17 Buy
+8
New +$19 ﹤0.01% 7210
2022
Q2 		– Sell
-84
Closed -$1K – 6996
2022
Q1 		$1K Buy
+84
New +$1.46K ﹤0.01% 6510

Other funds holding BTCY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFCL
Strengthening Families & Communities LLC Boston, Massachusetts $450M AUM 41.19% 1-Year Est. Return
AWM
AE Wealth Management Topeka, Kansas $21.5B AUM 26.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

JP Morgan Chase's BTCY Position: Q4 2023 in Review

JP Morgan Chase sold out of Biotricity, Inc. Common Stock (BTCY) in Q4 2023, closing a stake of 8 shares — an estimated $17 sold.

JP Morgan Chase first reported a position in BTCY in Q1 2022 and held it in 2 quarters. The position peaked at $1K in Q1 2022. 21 funds tracked by Wall St. Rank hold BTCY as of Q4 2023.

  • JP Morgan Chase reported no remaining Biotricity, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • JP Morgan Chase sold 8 Biotricity, Inc. Common Stock shares in Q4 2023, an estimated $17.
  • JP Morgan Chase first reported a position in Biotricity, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • JP Morgan Chase's Biotricity, Inc. Common Stock position peaked at $1K in Q1 2022.
  • 21 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q4 2023.

Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.